Southlake, TX – According to filings with the U.S. Securities and Exchange Commission, OncoNano Medicine is raising $68,407,469.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Martin Driscoll played a…
Southlake, TX – According to filings with the U.S. Securities and Exchange Commission, OncoNano Medicine is raising $60,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Martin Driscoll played a…
Southlake, TX – According to filings with the U.S. Securities and Exchange Commission, OncoNano Medicine is raising $60,000,000.00 in new funding. Sources indicate as part of senior management Interim CEO, Alvaro Guillem played a key…